Home › Trial NCT01361113
Neoadjuvant Pazopanib in Renal Cell Carcinoma
- Trial IDNCT01361113
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorUNC Lineberger Comprehensive Cancer Center
- Enrollment21
- Start date2011-06
- ConditionsRenal Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.